Symplekin, a novel type of tight junction plaque protein by unknown
Symplekin, a Novel Type of Tight Junction Plaque Protein 
Brigitte H. Keon, Stephan Sch~ifer, Caecilia Kuhn, Christine Grund, and Werner W. Franke 
Division of Cell Biology, German Cancer Research Center, D-69120 Heidelberg, Germany 
Abstract. Using a monoclonal antibody we have identi- 
fied and cDNA-cloned a novel type of protein local- 
ized, by light and electron microscopy, to the plaque 
associated with the cytoplasmic face of the tight junc- 
tion-containing zone (zonula occludens) of polar epi- 
thelial cells and of Sertoli cells of testis, but absent from 
the junctions of vascular endothelia. The ~3.7-kb 
mRNA encodes a polypeptide of 1142 amino acids (cal- 
culated molecular weight 126.5 kD, pI 6.25), for which 
the name "symplekin" (from Greek cyag~tn~.~  new, to tie 
together, to weave, to be intertwined) is proposed. 
However, both the mRNA and the protein can also be 
detected in a wide range of cell types that do not form 
tight junctions or are even completely devoid of any 
stable cell contacts. Careful analyses have revealed that 
the protein occurs in all these diverse cells in the nucle- 
oplasm, and only in those ceils forming tight junctions is 
it recruited, partly but specifically, to the plaque struc- 
ture of the zonula occludens.  We discuss symplekin as a 
representative of a group of dual residence proteins 
which occur and probably function in the nucleus as 
well as in the plaques exclusive for either tight junc- 
tions, adherens junctions, or desmosomes. 
T 
HE tight junction (zonula occludens) is a fundamen- 
tal  type  of  intercellular junction  that  occurs  in 
polarized epithelia and certain endothelia and is 
believed to provide a permeability barrier to prevent para- 
cellular transport of molecules and particles and to restrict 
the lateral diffusion of membrane lipids and proteins (for 
reviews  see  Pinto  da  Silva  and  Kachar,  1982; Madara, 
1988;  Simons,  1990; Citi,  1993; Gumbiner,  1993; Hirsch 
and Noske, 1993). Ultrastructurally, tight junctions repre- 
sent  a  system of linear  close  contacts  between the  two 
plasma  membranes  which  on  freeze-fractures along  the 
hydrophobic plane appear as a  network of anastomizing 
strands. Unlike the diverse adhering junctions, however, 
information on the molecular composition, the assembly 
and  the  functional regulation  of  tight  junctions  is  still 
scarce, and only recently the first transmembrane protein, 
occludin, has been described (Furuse et al.,  1993; Ando- 
Akatsuka et al., 1996). 
In addition, a number of cytoplasmic proteins have been 
reported to be associated with the loosely woven plaque 
structure  undercoating  the  zonula  occludens. Some  of 
these components have only been  identified as antigens 
whereas others have been characterized by cDNA-cloning 
and biochemical studies: 
Protein ZO-1 (Mr 220 K; 1,745 amino acids (aa)l; Mr 195 
kD; Itoh et al., 1993; Willot et al., 1993), appearing in two 
isoforms, is a component of the plaque of the apical zonula 
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occludens of polar epithelia as well as of the junctional belt 
of vascular endothelia (Stevenson et al., 1986; Anderson 
et al.,  1988; Kurihara et al.,  1992; Balda and Anderson, 
1993)  and  in  the  "junctional specializations"  of Sertoli 
cells of testis (Stevenson et al.,  1986; Byers et al., 1991), 
but has also been described in the plaques of the small 
junctions connecting the basal processes of podocytes of 
kidney glomeruli (Schnabel et al.,  1990), in certain adher- 
ens junction plaques (e.g., Itoh et al., 1991) and as a mem- 
brane-associated or "free" cytoplasmic protein not incor- 
porated  into  junctions  (Howarth  et  al.,  1992,  1994; 
Miragall et al., 1994; Petrov et al., 1994; Van Itallie et al., 
1995). On the basis of amino acid sequence comparisons 
this protein has been grouped into the MAGUK (mem- 
brane-associated guanylate kinases) family of proteins (for 
reviews see Tsukita et al., 1993; Kim, 1995). 
Protein ZO-2 (Mr 160 K; Gumbiner et al., 1991; Jesaitis 
and Goodenough, 1994) has been identified in zonula  oc- 
cludens plaques of polar epithelia and vascular endothelia, 
is highly homologous to ZO-1  and also a member of the 
MAGUK protein family. 
Cingulin (two forms of Mr 108 K and 140 K; Citi et al., 
1988) was originally isolated from an avian intestinal brush 
border  fraction and  immunolocalized specifically to  the 
zonula  occludens  plaque  of polar epithelia and vascular 
endothelia (Citi et al., 1989). Biochemical analyses of the 
purified, heat-stable Mr 108 K protein and partial cDNA 
cloning have revealed that cingulin is a coiled-coil dimer 
with structural similarities to certain cytoskeletal proteins 
(Citi et al., 1990). 
Antigen 7H6 (Mr 155 K or 175 K, depending on the spe- 
cies;  1,125 aa in the rat protein; Zhong et al., 1993, 1994; 
Satoh et al., 1996) is an antigen which has been localized 
specifically to the zonula occludens plaque of polar epithe- 
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cells. 
Antigen TJ1 (Kapprell et al., 1990) occurs at the zonula 
occludens plaque specifically in polar epithelia but not in 
endothelial cells. 
Additionally, several other proteins have been localized 
to the zonula occludens plaque, including actin (Stevenson 
and Begg, 1994; Nusrat et al.,  1995) and the GTP-binding 
proteins, rab3B (Weber et al.,  1994) and rub13 (Zahraoui 
et al., 1994). 
In the course of our studies on plaque proteins of the 
junctional  complexes  of epithelial  cells,  we  obtained  a 
mAb  reactive with  a  single protein distinctly located at 
tight junctions of diverse epithelia but not endothelia. Us- 
ing this mAb, we have cDNA-cloned and sequenced the 
corresponding  mRNA  and  identified  a  novel  type  of 
plaque protein, named  symplekin.  In  addition, we show 
that symplekin is not synthesized in relation to the differ- 
entiation of polar epithelial cells, but is rather a  house- 
keeping protein in a wide range of diverse cells, including 
many that do not form tight junctions, and that in all these 
cells symplekin can be detected in the nucleoplasm. 
Materials and Methods 
Tissues and Cultured Cells 
Specimens of human colon, duodenum, liver, stomach, pancreas, epider- 
mis, esophagus, tongue, heart, testis, lymph nodes, and brain, as well as 
colon and liver carcinomas were obtained and snap-frozen in isopentane 
cooled by liquid nitrogen to about -140°C as described (Moll et aL, 1982, 
1986; Schiller et al., 1994,  1996).  Cell culture lines used included human 
colon adenocarcinoma Caeo-2 and HT29, primary liver carcinoma PLC, 
mammary carcinoma  MCF-7,  vulvar squamous cell  carcinoma-derived 
SVS0 fibroblasts, glioma U 333 CG/343 MG, erythroleukemia K562, kera- 
tinocyte HaCaT, various cultures of endothelial cells of umbilical cord 
veins (HuVEC cells), Burkitt lymphoma Raji cells, calf lens-forming cells, 
rat vascular smooth muscle-derived RVF-cells, and mouse 3T3-L1 pre- 
adipocytes (for sources of cell lines, see American Type Culture Collec- 
tion, Rockville, MD, and previous reports from this laboratory, e.g., Franke 
et al., 1980, 1987; Achtstatter et al., 1986b; Knapp and Franke, 1989; Sch~ifer 
et al., 1994).  Cells were  maintained under standardized conditions and 
routinely grown to confluence if not indicated otherwise. 
Antibodies and Antibody Production 
The mouse hybridoma line secreting mAb Sym-TJ-E150 was obtained ac- 
cording to previously described methods in the course of a  program de- 
signed to raise antibodies against junctional proteins (see Sch~ifer et al., 
1996).  The resultant hybridoma supernatants were screened by immuno- 
blotting of proteins of fractions from human Caco-2 ceils, separated by 
SDS-PAGE, and by immunofluorescence microscopy of Caco-2 cell mono- 
layers on cover slips (see below).  Guinea pig antibodies to synthesized 
peptides  (SchnOlzer et  al.,  1992;  Nuber et  al.,  1996)  derived  from the 
amino acid sequence of the antigen of Sym-TJ-E150 (see below) were pre- 
pared by Drs. H.-R. Rackwitz and M. Schn01zer in our laboratory essen- 
tially as described (see Demlehner et al., 1995).  In the experiments re- 
ported  here,  antibodies against the sequence of aa 532-548  (one-letter 
code) FTKVVLEAPLITESALE were routinely used. For comparison we 
also used mAb ZA-TJ1 described earlier (Kapprell et al., 1990). 
Murine  mAbs as  well  as  rabbit  and  guinea pig  antibodies  to  des- 
moplakin were as described (e.g., Franke et al., 1982; Cowin et al., 1985). 
Rabbit  antibodies to  E-cadherin, a-catenin, and  13-catenin  were gener- 
ously provided by Dr. R. Kemler (Max Planck Institute for Immunology, 
Freiburg i. Br., Germany). Affinity-purified rabbit antibodies to protein 
ZO-1 were from Zymed Laboratories, Inc. (San Francisco, CA). 
Secondary antibodies used for immunofluorescence microscopy were 
Texas Red- and FITC-conjugated goat antibodies to immunoglobulins of 
mouse and rabbit or guinea pig, respectively. For immunoblotting, HRP- 
conjugated antibodies to mouse or guinea pig immunoglobulins (Dianova, 
Hamburg, Germany) were used. 
cDNA Library Screening and DNA Sequencing 
A hgt11 human colon carcinoma cDNA expression library (cf. Franke et 
al., 1989) was screened using mAb Sym-TJ-E150. Approximately 1 ×  106 
plaques were evaluated using a protocol from Stratagene (La Jolla, CA). 
Expression  of the  desired  antigen  was  detected  by  ECL  (Amersham 
Buchler GmbH, Braunschweig, Germany)-enhanced immunoblotting un- 
der stringent conditions. Under the conditions used a single positive 2.1-kb 
cDNA clone (2a-l-2B) was isolated and exonuclease deletion fragments 
were generated using a "nested deletion" kit (MBI Fermentas, Frankfurt, 
Germany),  subcloned  into  pBluescript  II  (SK-)  (Stratagene),  and  se- 
quenced in both directions. A 700 bp deletion fragment corresponding to 
the 5-prime end of clone 2a-1-2B was used to generate randomly primed 
probes for rescreening the same library from which three clones (Sym-3a, 
-5b, and -9a) were isolated, sub-cloned and partially sequenced along both 
strands. Clone  Sym-5b was determined to  be  a  full-length clone,  fully 
overlapping with clone 2a-l-2B and containing an additional 1.5-kb seg- 
ment,  including  a  "Kozak  sequence"  (Kozak,  1989)  before  the  start 
codon. Clone Sym-5b was sequenced completely in both directions after 
the generation and subcloning of PstI endonuclease restriction fragments. 
Additionally, the entire clone was sequenced along both strands, using in- 
ternal  oligonucleotide primers. Sequence alignment, analyses, and data 
base searches were  accomplished using the software program package 
HUSAR (Heidelberg Unix Sequence Analysis Resources). 
RNA Isolation, Northern Blot Analysis, and In Vitro 
Transcription and Translation 
Total RNA from diverse human cultured cell lines and mouse 3T3 cells, 
and total or poly(A) + mRNA from various human tissues as well as colon 
and hepatocyte carcinomas were isolated essentially as described (Sch~ifer 
et al., 1994, 1996).  Northern blot analyses were also as described (Sch~ifer 
et al., 1994) using 32p-labeled antisense riboprobes derived from clone 2a- 
1-2B. 
Clone Sym-5b was transcribed and translated in vitro in the presence of 
35S-methionine in a rabbit reticulocyte lysate system (Promega, via Serva, 
Heidelberg, Germany) according to manufacturer's instructions. Products 
were  separated  by  SDS-PAGE,  stained  with  Coomassie blue  (Sigma 
Chem. Co., St. Louis, MO), destained, soaked for 15 min in Amplify solu- 
tion (Amersham), dried, and exposed to X-ray film (Kodak, via Siemens, 
Stuttgart, Germany) for 4 h at -80°C. 
Cell Fractionation 
Human carcinoma cells of lines PLC or Caco-2 grown to confluence in 10 
cm diameter sterile culture dishes were washed three times with PBS and 
either fractionated or dissolved directly in detergent buffer for gel electro- 
phoresis as described below. Typically 10 or 20 dishes were used for a frac- 
tionation. 2 ml of ice-cold hypotonic buffer (1 mM NaHCO  3 adjusted to 
pH 7.0 and containing 0.1 mM PMSF) were added per dish and cells were 
left on ice 15-30 rain to swell. Cells were then collected by scraping with a 
rubber policeman and manually homogenized in a  glass-glass homoge- 
nizer by 15 return strokes. An aliquot was removed for analysis as "total 
cell homogenate" and the disrupted cell homogenate was centrifuged at 
1500 g for 40 min at ~4°C. The supernatant obtained was removed, and an 
aliquot taken for analysis (1,500-g supernatant). The pellet (1,500-g pel- 
let), containing the bulk of the molecular mass 150 K protein, was either 
directly extracted with detergent (see below), or after removal of a small 
aliquot for analysis was washed by resuspension in an equal volume of ho- 
mogenization buffer followed by recentrifugation for 15 min at 13,000 g 
and 4°C in a microcentrifuge. The supernatant was recovered and an ali- 
quot removed for analysis (wash supernatant). The washed pellet material 
was  again  resuspended  in  a  small defined  volume of  homogenization 
buffer, and 100 mM bicarbonate buffer (pH 9) was added to a final con- 
centration of 10 raM. After resuspension and centrifugation for 15 rain at 
13,000 g  and 4°C, the supernatant was removed (pH 9 extract). In some 
cases, the pellet was further extracted with a 500 mM NaCI solution and 
centrifuged as specified above to recover a high salt extract. The final pel- 
let was then extracted with non-ionic detergent as described below, or di- 
rectly solubilized in SDS-containing buffer. 
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mAb Sym-TJ-E150 in diverse cultured human cell lines. (a) Coo- 
massie  brilliant  blue-stained  SDS-PAGE  of total  cellular  pro- 
teins,  and  (a')  the  corresponding  radiogram  showing  immuno- 
chemiluminescence detection  of the  antigen  in  ceils of various 
lines: SV-40-transformed fibroblasts "SV80" (lane 1), colon carci- 
noma  Caco-2 (lane 2), liver carcinoma PLC (lane 3),  glioma U 
333 CG/343  (lane 4), erythroleukemia K562  (lane 5), and colon 
carcinoma HT29 (lane 6). Note positive reactions of comparable 
intensities in all cells, independent  of whether  they form stable 
cell--cell  junctions (lanes 2, 3, and 6) or not (lanes 1, 4, and 5). (b) 
Immuno-chemiluminescence detection  of the same  antigen (ar- 
row) after two-dimensional non-equilibrium pH gradient electro- 
phoresis  (NEPHGE)  separation  of a Triton X-114-soluble frac- 
tion  (see  Materials  and  Methods)  from  PLC cell homogenates 
(NEPHGE, from left to right; SDS-PAGE from top to bottom). 
SDS-PAGE reference proteins (dots along the left margin) were 
of M  r 200 K, 116 K, 97 K, and 66 K, respectively. 
Detergent Extraction and Phase Separation 
For detergent affinity analysis of proteins (for review see Pryde, 1986), 1 ml 
of ice-cold Triton X-114 buffer (25 mM Tris-HCl,  pH 7.5, 0.5% TXl14, 
150 mM NaCI, I mM EDTA, 0.1 rnM PMSF) was added  directly to each 
10-cm diameter dish containing  cell monolayers briefly washed with PBS 
and cells were then collected by scraping with a rubber policeman. Alter- 
natively, cells were disrupted  by hypotonic swelling and centrifuged as de- 
scribed above, and the resultant  1,500-g pellets were solubilized in approx- 
imately equal volumes of ice-cold twice concentrated Triton X-114 buffer. 
Cells or pellet material  were homogenized  by 10 return strokes  with a 
glass-glass homogenizer (see above) and centrifuged for 15 min at 13,000 g 
and 4°C to remove the detergent insoluble pelletable material ("TX  114 in- 
soluble").  The supernatant  was transferred  first to fresh tubes on ice and 
then to a 30°C water bath for 3 rain to induce phase separation of deter- 
gelat micelles. A  detergent-poor aqueous phase  ("TXl14 soluble  aque- 
ous") and a detergent-rich  pellet ("TXll4 soluble detergent") were recov- 
ered by low speed centrifugation  (300 g) at room temperature for 3 min. 
Figure 2.  Analyses of cDNA clone Sym-5b encoding symplekin. 
(a) Northern blot showing the detection of an ~3.7-kb mRNA in 
diverse cultured human cell lines such as colon carcinoma Caco-2 
(lane 1), SV-80 fibroblasts (lane 2), HaCaT keratinocytes (lane 3), 
glioma U  333 CG/343  (lane 4), in mouse 3T3-L1  preadipocytes 
(lane 5), and in human liver (lane 6) and colon (lane 7) carcinoma 
tissues. The widespread occurrence of a 3.7-kb symplekin mRNA 
in tight junction-forming cells as well as in cells that do not form 
any stable cell-cell contacts, is consistent  with the  immunoblot 
results shown in Fig. 1 a.  Size markers were 4.4 kb and 2.37 kb 
from the top, respectively. (b)  Immuno-chemiluminescence de- 
tection of symplekin as a M r 150 K polypeptide upon SDS-PAGE 
(8%),  in PLC cell extracts by both mAb Sym-TJ-E150 (lane 1) 
and guinea pig antibodies raised against an aa sequence derived 
from cDNA clone Sym-5b (lane 2), in a bile canaliculi-enriched 
fraction from mouse liver (lane 3; lower bands represent degrada- 
tion products; lane 4, cell extract from PLC cells, used here for 
reference) isolated according to Itolyet et al. (1991).  Lane 5, au- 
toradiogram showing the Mr 150 K polypeptide as the product of 
cDNA clone Sym-5b, upon combined transcription  and transla- 
tion using [35S]methionine. SDS-PAGE reference proteins (bars 
along the left margin) were of Mr 200 K, 116 K, and 97 K, respec- 
tively. 
Gel Electrophoresis, Immunoblotting, and Protein 
Sequence Characterization 
Conditions  for SDS-PAGE in 8 or 10% acrylamide gels or for two-dimen- 
sional electrophoresis  and for immunoblotting  have been given elsewhere 
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MTQL 
121  TCTAC~GGTGGCCCTGCAGTGGATGGTAAAGTCACGGGT~TTAGCGAGCTACAGGAGGCCTGCTGGGACATGGTATCTGCCATGGCGGGGGACATCATCCTGCTATTGGACTCTGACA 
5  YKVALQWMVKSRVISELQEACWDMVSAMAGDIILLLDSDN 
241  ATGACGGCATCCGCACCCACGCCATC~GTTTGTGGAGGGCCTCATTGTCACCCTGTCACCCCGCATGGCTGACTCAGAGATACCCCGACGCCAGGAGCATGATATCAGCCTGGACCGCA 
45  DGIRTHAIKFVEGLIVTLSPRMADSEIPRRQEHDISLDRI 
361  TCCCTCGTGACCACCCCTACATCCAGTAC~CGTGCTATGGG~GAGG~GGCAGCCTTGGAG~AGCTGCTT~GTTCATGGTGCACCCTGCCATCTCCTCCATC~CCTGACCACAG 
85  PRDHPYIQYNVLWEEGKAALEQLLKFMVHPAISSINLTTA 
481  CGCTGGGCTCCCTTGCC~TATCGCCCGCCAGAGACCCATGTTCATGTCTGAGGTGATCCAGGCCTATGAAACTCTGCATGCC~CCTGCCCCCGACGCTGGCCAAATCGCAGGTGAGCA 
125  LGSLANIARQRPMFMSEVIQAYETLHANLPPTLAKSQVSS 
601  GTGTGCGT~G~TCTG~GCTGCACCTGTTGAGTGTGCTG~GCACCCGGCTTCCTTGGAGTTCCAGGCCCAGATCACCACCCTGCTGGTGGACCTGGGCACACCTCAGGCCGAGATCG 
165  VRKNLKLHLLSVLKHPASLEFQAQITTLLVDLGTPQAEIA 
721  CCCGC~CATGCCGAGCAGC~GGACACCCGC~GCGGCCCC~CGATGACTCGGACTCCACACTC~G~GATG~GCTGGAGCC~CCTGG~GAGGACGATGAGGACAAAGACTTGG 
205  RNMPSSKDTRKRPRDDSDSTLKKMKLEPNLGEDDEDKDLE 
841  AGCCAGGCCCGTCGGGGACCTCG~GGCCTCAGCGCAGATCTCCGGCCAGTCAGACACGGACATCACAGCTGAGTTCCTGCAGCCTCTGCTGACGCCTGAT~TGTGGCT~TCTGGTCC 
245  PGPSGTSKASAQISGQSDTDITAEFLQPLLTPDNVANLVL 
961  TCATCAGCATGGTGTACCTACCCGAGGCCATGCCAGCCTCCTTCCAGGCCATCTACACCCCCGTGGAGTCAGCAGGCACGG~GCCCAGATC~GCACCTGGCTCGGCTCATGGCCACAC 
285  ISMVYLPEAMPASFQAIYTPVESAGTEAQIKHLARLMATQ 
1081  AGATGACAGCTGCCGGACTGGGACCAGGTGTAGAGCAGACCAAACAGTGC~GGAGGAGCCC~GGAGGAG~GGTGGTG~GACAGAGAGCGTCCTGATC~GCGGCGCCTGTCAGCCC 
325  MTAAGLGFGVEQTKQCKEEPKEEKVVKTESVLIKRRLSAQ 
1201  AGGGCC~GCCATCTCGGTGGTGGGTTCCCTGAGCTCCATGTCCCCCCTGGAGG~GAGGCACCGCAGGCC~GAGGAGGCCAGAGCCCATTATCCCTGTCACTCAGCCCCGGCTGGCAG 
365  GQAISVVGSLSSMSPLEEEAPQ  A  KRRPEPII  P  VTQPRLAG 
1321  GCGCTGGTGGGCGC~GAAAATTTTCCGTCTCAGCGACGTGCTG~GcCCCTTACCGATGCCCAGGTGG~GCCATG~GCTGGGCGCTGTG~GCGGATC~TGCGGGCTGAG~GGCTG 
405  AGGRKKIFRLSDVLKPLTDAQVEAMKLGAVKRILRAEKAV 
1441  TGGCCTGCAGCGGGGCAGCCCAGGTCCGCATAAAGATCCTGGCCAGC~TGGTGACACAGTTC~CTCGGGCCTG~GGCGGAGGTCCTGT~CTTCATCCTGGAGGATGTGCGGGCCCGCC 
445  ACSGAAQVRIKILASLVTQFNSGLKAEVLSFILEDVRARL 
1561  TGGACCTGGCCTTCGCCTGGCTCTACCAGGAGTAC~CGCCTACCTGGCCGCAG~TGCCT~GGGCTCCCTGGAC~GTATGAGGACTGCCTCATCCGCCTGTTGTCTGGCCTGCAGGAGA 
485  DLAFAWLYQEYNAYLAAGASGSLDKYEDCLIRLLSGLQEK 
1681  ~CCAGACCAG~GGATGGGATCTTCACC~GGTTGTGCTGGA~CGCCACTCATCACAGAGAGTGCCCTGGAGGTGGTCCGC~GTACTGCGAGGATGAGAGTCGCACCTATCTGGGCA 
525  PDQKDGIFTKVVLEAPLITESA  L  EVVRKYC  ED  ESRTYLGM 
1801  TGTCCACACTTCGAGACCTGATCTTC~GCGCCCGTCCCGCCAGTTCCAGTACCTGCATGTCCTCCTCGACCTCAGCTCCCATGAG~GGAC~GGTGCGCTCCCAGGCCCTGCTGTTCA 
565  STLRDLIFKRPSRQFQYLHVLLDLSSHEKDKVRSQALLFI 
1921  TC~CGCATGTATGAG~GGAGCAGCTGCGGGAGTATGTGGAGAAATTTGCCCTC~CTACCTGCAGCTCCTGGTGCACCCC~CCCACCGTCTGTGCTGTTTGGAGCTGAC~GGACA 
605  KRMYEKEQLREYVEKFALNYLQLLVHPNPPSVLFGADKDT 
2041  CAGAGGTGGCAGCACCCTGGACGGAGGAGACA~TG~GCAGTGTCTGTACCTCTACCTGGCCCTCCTGCCTCAG~CCAC~GCTGATCCACG~CTGGCGGCCGTGTACACTG~GCCA 
645  EVAAPWTEETVKQCLYLYLALLPQNHKLIHE  AAVYTEA  L  I 
2161  TCGCCGACATC~GCGGACGGTGCTGAGGGTCAT~AGCAGCCGATCCGAGG~TGGGCATG~CTCCCcG~A~CTGCTCCTGCTGGTGGAAAATTGTCCC~GGGAG~AGAGACACT~G 
685  ADIKRTVLRVIEQPIRGMGMNSPELLLLVENCPKGAETLV 
2281  TCACGAGATGTCTGCACAGCCTCACAGACAAAGTCCCACCCTCCCCAGAGCTGGTG~GCGGGTCCGGGATCTCTACCAC~GCGACTGCCAGACGTCCGCTTCCTCATCCCGGTG~TCA 
725  TRCLHSLTDKVPPSPELVKRVRDLYHKRLPDVRFLIPVLN 
2401  ATGGGCTGGAG~GAAAGAGGTGATCCAGGCCCTGCCT~CTCATC~CTC~CCCCATCGT~GTG~GG~GTCTTC~CCGCCTGCTGGGCACCCAGCATGGTGAGGGAAACTCAG 
765  GLEKKEVIQALPKLIKLNPIVVKEVFNRLLGTQHGEGNSA 
2521  CCTTGTCCCCGCTG~CCCTGGAGAGCTCCTGATCGCATTACAC~CATTGACTCCGTG~GTGCGACATGAAATCCATCATCAAAGCCACC~CCTGTGCTTTGCGGAGCGG~CGTGT 
805  LSPLNPGELLIALHNIDSVKCDMKSIIKATNLCFAERNVY 
2641  ACACGTCAGAGGTGCTGGCCGTGGTGATGCAGCAGCTGATGGAGCAGAGCCCCCTGCCCATGCTGCTCATGAGGACCGTCATCCAGTCCCTGACCATGTACCCCCGCCTGGGGGGCTTCG 
845  TSEVLAVVMQQLMEQSPLPMLLMRTVIQSLTMYPRLGGFV 
2761  TCATG~CATCCTGTCCCGCCTCATCATG~GCAGGTGTGG~GTACCCC~GGTGTGGGAGGGCTTcATC~GTGC~CCAGCGCACAAAGCCCCAGAGCTTCCAG~TCATCCTGCAGC 
885  MNILSRLIMKQVWKYPKVWEGFIKCCQRTKPQSFQV  I  LQL 
2881  TGCCGCCCCAGCAGCTGGGAGCCGTCTTTGAC~GTGCCCAGAGCTCCG~AGCCCCTGCTGGCCCATGTCCGCTCCTTCACCCCCCACCAGC~GCTCACATCCCT~CTCCATCATGA 
925  PPQQLGAVFDKCPELREPLLAHVRSFTPHQQAHIPNSIMT 
3001  CCATCTTGGAGGCCAGCGGC~GCAGGAGCCAGAGGCC~GGAGGCGCCTGCGGGGCCCTTGGAGGAGGATGATCTGGAGCCCCTGACCTTGGCCCCGGCCCCAGCACCCCGGCCCCCTC 
965  ILEASGKQEPEAKEAPAGPLEEDDLEPLTLAPAPAPRPpQ 
3121  AGGACCTCATCGGCCTGCGACTGGCCCAGGAG~GGCCTTAAAGCGGCAGCTGGAGGAGG~CAG~GCTG~GCCGGGAGGAGTGGGAGCCCCCTCCTCTTCCTCCCCCTCTCCCTCTC 
1005  DLIGLRLAQEKALKRQLEEEQKLKPGGVGAPSSSSPSPSP 
3241  CGTCGGCCCGGCCAGGCCCGCCCCCGTCTGAGG~GCCATGGATTTCCGGGAGGAGGGGCCTGAGTGCGAGACCCCGGGCATCTTCATCAGCATGGATGACGACTCGGG~CTGACCGAGG 
1045  SARPGPPPSEEAMDFREEGPECETPGIFISMDDDSGLTEA 
3361  CCGCGCTGTTGGACTCTAGT~TCGAGGGCCCCCTACCC~GGAGACGGCAGCGGGCGGGCTGACCTTG~GGAGGAGCGGAGCCCCCAGACCCTCGCACCTGTTGGAG~GATGCTATGA 
1085  ALLDSSLEGPLPKETAAGGLTLKEERSPQTLAPVGEDAMK 
3481  AGACTCCCAGCCCGGCTGCCGAGGACGCCAGGG~CCCGAGGCC~GGGG~CAGCTGACGGGGCTCGAGGGGGAAAGGGGGTGGGACAGGGACTCGGGGCTGGGGGACGGGGCGGGGCT 
1125  TPSPAAEDAREPEAKGN8 
3601  TGACCTGCGGGTGCTTTGCCTTAAAAAGAAATAAAAGATGTG~CTTGGA2~G  3669 
Figure 3.  Nucleotide sequence of cDNA clone Sym-5b and deduced aa sequences of human symplekin. The cDNA of 3,668 nucleotides 
contains an open reading frame encoding a 1051-aa polypeptide with a predicted molecular mass of 116.5 kD and a pI of 8.4. The de- 
rived aa sequence has been confirmed by the finding that 13 segments were identical by electrospray mass spectroscopy to fragments ob- 
tained in a tryptic digest of the isolated native protein. Sequence comparisons using the BLAST-Algorithm revealed no significant ho- 
mologies to known proteins. These sequence data are available from GenBank, EMBL, and DDBJ under the accession code U49240. 
(e.g., Franke et al., 1981; Achst~itter et al., 1986a).  Antibodies bound were 
detected by chemiluminescence (1-min incubations with ECL reagents, 
20 s-5 min film exposure). 
For mass identification of tryptic fragments from the native protein the 
following methods were  used. The  Mr  150  K  antigen was partially en- 
riched by batch DEAE anion exchange of the TX114 aqueous fraction ac- 
cording  to  standard  protocols  (Pharmacia,  Freiburg  i.  Br.,  Germany). 
ElectrophoreticaUy  separated  proteins  were  electroblotted  to  PVDF 
membranes, a narrow strip was cut along the outer border of the stained 
protein and immunoblotted with the mAb, Syrn-TJ-El50, to precisely lo- 
calize the antigen. After removal of the identified bands, the entire blots 
were then probed with the mAb to confirm inclusion of the antigen on the 
excised PVDF membrane. 
Enzymatic digests were performed On PVDF-blotted protein with mod- 
ified trypsin (Promega, Madison, WI) by incubation with protein samples 
(enzyme/substrate ratio 1:10) in 10% acetonitrile and 50 mM NH4HCO3, 
pH 8.5,  overnight at 37°C in an in-house constructed microincubator (P. 
Jedrzejewski, personal communication). Analyses of tryptic digests were 
performed using capillary liquid chromatography coupled to an electro- 
spray mass spectrometer system. Chromatography was performed with an 
Applied Biosystems (San Jos6, CA) model 140A dual syringe pump sys- 
tem. Tryptic digests were separated on a fused silica capillary column (0.2 
x  250 mm) packed in house with Vydac (The Separations Group, Hespe- 
ria, CA) 5/~m, 300 ~, pore, Cts packing material, equilibrated in 0.065% 
TFA (solvent A). Tryptic peptides were eluted with a linear gradient pro- 
gram from 10 to 60% solvent B (0.05% TFA in 80% acetonitrile) over 90 
rain, followed by a gradient from 60 to 100% solvent B over 15 rain, at a 
flow rate  of 0.5  ixl/min.  Etectrospray  mass spectra were  acquired  on a 
Finnigan MAT TSQ7000 triple quadrupole mass spectrometer (Palo Alto, 
CA) equipped with an ESI ion source. Obtained masses were compared 
to predicted masses of peptides generated from a theoretical tryptic digest 
of the  derived  amino acid  sequence from cDNA  clone  Sym-5b  using 
Sherpa software (obtained from Dr. A. Taylor, University of Washington, 
Seattle, WA). 
Immunofluorescence Microscopy 
Immunofluorescence microscopy was done on both sections of frozen tis- 
sues and monolayers of cultured cells. Particular care was taken in the 
protocols to avoid protein losses by extraction or redistribution during in- 
cubation (see  also Krohne and Franke,  1980;  Ankenbauer et al.,  1989; 
Melan and SludeL 1992).  For immunohistochemistry, samples of frozen 
tissues were sectioned (1-4 i~m) with a Jung CM300 cryostat (Leica, Ben- 
sheim, Germany), mounted on poly-lysine treated coverslips, briefly air- 
dried, and then fixed according to one of the following protocols: (A) 10 
rain in -20°C acetone; (B) 20 rain in modified Carnoy solution (60% etha- 
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plekin from human liver car- 
cinoma  PLC  cells.  (a)  Coo- 
massie brilliant blue-staining 
of  proteins  separated  by 
SDS-PAGE  (a)  and  (a'  and 
a")  immuno-chemilumines- 
cence  detection  of  symple- 
kin  by  both  the  guinea  pig 
polyclonal antibodies (a') and 
mAb Sym-TJ-E150 (a"), showing the distribution of symplekin in the following fractions from PLC cell extracts (for designations see 
Materials and Methods): total cell homogenate (lane 1), 1,500-g supernatant (lane 2), 1,500-g pellet (lane 3), wash supernatant (lane 4), 
pH 9 extract (lane 5), Triton X-114 insoluble (lane 6), Triton X-114 soluble aqueous phase (lane 7), and Triton X-114 soluble detergent 
phase (lane 8). Upon hypotonic cell disruption, symplekin Was detected in the low-speed pellet from which it could be partially ex- 
tracted at elevated pH and ionic strength, but was only fully released by solubilization with non-ionic detergent, the removal of which, 
however, did not affect its solubility. Note proteolytic susceptibility of symplekin under certain conditions, resulting in the appearance 
of lower bands (a', a"). Coelectrophoresed molecular mass markers (lane R in a) were of 200 K, 116 K, 97 K, and 66 K, respectively. 
nol, 30% chloroform, 10 acetic acid), followed  by a 10-min ethanol wash; 
(C) 15 rain in 2% formaldehyde in PBS, freshly made from paraformalde- 
hyde, followed by a quick water rinse, 5 rain quenching in 50 mM NH4CI 
in PBS, and another PBS wash. 
For immunocytochemistry of cell cultures, cells grown on poly-lysine 
coverslips were washed three times briefly in PBS containing 2 mM MgC12 
and then fixed at -20°C in methanol (7 rain) and acetone (30 s). 
Cell and tissue specimens were incubated with the antibodies according 
to one of the following procedures: (a) Primary antibodies were directly 
applied for either 15, 30 or 120 min, followed by three 5 rain PBS washes 
before application of secondary antibodies for either 15 or 30 rain. (b) 
Specimens were either treated as in (a) or were incubated in PBS contain- 
ing 0.2% Triton X-100 for 2, 3, or 5 min, and then briefly washed in PBS 
before application of antibodies. (c) As under (b), except that all PBS so- 
lutions used contained 0.5 or 2.0 mM MgCI2. After antibody binding, spec- 
imens were then washed again in PBS, rinsed in water, fixed in ethanol for 
5 min, dried, and mounted. Immunofluorescence was observed and docu- 
mented with a Zeiss Axiophot photomicroscope (Carl Zeiss, Jena, Ger- 
many). 
Confocal laser-scanning immunofluorescence microscopy was done on 
a Zeiss LSM 410 UV (Carl Zeiss). For simultaneous double-label fluores- 
cence, an Argon ion laser operating at 488 nm and a Helium-neon laser 
operating at 543 nm were used together with a band-pass filter combina- 
tion of 510-525 and 590-610 for visualization of FITC and Texas Red fluo- 
rescence, respectively.  RGB images  were taken in high resolution mode 
using 1,024 ×  1,024 image points (pixels)  and 2 s scan times.  Regularly 
noise levels were reduced by several line averagings of the scans. Projec- 
tion images were created from 0.8-1xm optical sections of tissue prepara- 
tions or cell layers. To verify the distribution of symplekin and ZO-1, the 
individual images were separated electronically by a 20 pixel off-set along 
the abscissa. 
Immunoelectron Microscopy 
Frozen tissue sections (5 mm) were prepared with a Jung CM300 cryostat 
(Leica), mounted on coverslips,  air-dried, and fixed in acetone at -20°C 
for 10 min. Cells grown on coverslips were fixed with 2% formaldehyde 
for 5 rain and then permeabilized with 0.1% saponin in PBS for 5 rain. The 
hybridoma supernatant containing mAb Sym-TJ-E150 was applied for 2 h. 
As secondary antibodies, anti-mouse IgG coupled to 5-nm colloid  gold 
particles  (Amersham) was  applied  overnight or  anti-mouse IgG  from 
Nanogold (Bio Trend, Cologne,  Germany), was applied for 3 h, followed 
in some experiments by silver enhancement for 3 min. Fixation with glu- 
taraldehyde, dehydration, and embedding were as described (for refer- 
ences see Rose et al., 1995), and electron micrographs were taken using a 
Zeiss electron microscope EM 910 (LEO  Electron Microscope Optics, 
Oberkochen, Germany). 
Results 
Immunoblot Analyses of the Sym-TJ-EI50 Antigen 
The antigen to antibody Sym-TJ-E150 was found by im- 
munoblotting of SDS-PAGE-separated proteins as a 150-K 
molecular mass polypeptide occurring in a  wide range of 
cultured human cell lines, including colon adenocarcinoma 
Caco-2  and  HT29, liver carcinoma PLC,  HaCaT kerati- 
nocytes,  SV-80  fibroblasts,  U333  CG/343  glioma,  and 
erythroleukemia 562 (Figs. 1, a  and a' and 2 b). On two- 
dimensional  gel  electrophoresis,  the  antigen  appeared 
with a pI ~6.5 (Fig. 1 b, shows NEPHGE). As we had, in 
our preliminary immunofluorescence microscopy experi- 
ments, localized the antigen to apical rings of cell--cell con- 
tacts in polarized epithelia, the detection of the antigenic 
polypeptide in non-epithelial cells, including some which 
never form any kind of stable cell-cell junctions, suggested 
that this protein, which we named symplekin, was wide- 
spread and might not be an exclusively junctional compo- 
nent. 
Isolation and Sequencing  of  cDNA Encoding  Symplekin 
To elucidate the identity and nature of the 150-K molecular 
mass polypeptide, we used mAb Sym-TJ-E150 to screen 
1 ×  106 plaques from a hgtll cDNA expression library de- 
rived from cultured cells of a human adenocarcinoma line 
as described in Materials and Methods. We initially cloned 
a positive phage recombinant (2a-l-2B) with a 2.1-kb open 
reading  frame which  included a  consensus  polyadenyla- 
tion signal. To detect mRNA represented by clone 2a-1- 
2B in various human cell lines and tissues, we performed 
Northern blot analyses using  a  riboprobe (Fig. 2  a). An 
mRNA of ~3.7 kb was detected in cultured polarized epi- 
thelial cells as well as in adenocarcinomas but also in non- 
epithelial cells such  as fibroblasts and  glioma cells,  thus 
corroborating our immunoblot findings. We were able to 
confirm that the Sym-5b cDNA clone encoded the Mr 150 
K antigen present in the tight junction plaques by several 
independent criteria: (a) Polyclonal guinea pig antibodies 
raised against  a 20-aa sequence derived from the cDNA 
clone also recognized the 150-K band on immunoblots of 
total PLC cell proteins (Fig. 2 b, lanes 1 and 2). (b) This 
protein was also recovered in the bile canaliculi-rich frac- 
tion from murine liver (Fig. 2 b, lane 3). (c) In vitro tran- 
scription and translation of the cDNA clone resulted in a 
polypeptide  electrophoretically identical  to  that  recog- 
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microscopy of frozen  sections 
through  human  tissues,  dem- 
onstrating the specific localiza- 
tion  of  symplekin  by  mAb 
Sym-TJ-E150 to the tight junc- 
tion-containing  apical  belt 
(zonula  occludens)  of  polar- 
ized  epithelia,  under  the  spe- 
cific  reaction  conditions.  (a) 
Stomach epithelium  (b, corre- 
sponding phase contrast; L, lu- 
men; S, submucosa). (c) Near- 
apical cross-section of the api- 
cal  region  in  a  differentiated 
colon  carcinoma,  showing  di- 
rectly  the  belt-like  immun- 
ostaining  in  this  plane.  (d) 
Pancreatic tissue (e, phase con- 
trast), showing near-apical stain- 
ing of symplekin in acinar alve- 
ok (left) and a duct (D). (f-h) In 
liver, symplekin immunostain- 
ing  is  exclusively  along  bile 
canaliculi where the tight junc- 
tions are (f, g). In double-label 
immunostaining, symplekin (g) 
and protein ZO-1  (h) colocal- 
ize at tight junctions in epithe- 
lial  cells  whereas  in  vascular 
endothelial  cells  only  protein 
ZO-1  is  detected  (V,  blood 
vessel).  (i)  Symplekin  at  the 
specialized junctions in Sertoli 
cells  of  testis.  (j)  Under  the 
conditions used, symplekin has 
not  been  detected  in  the  epi- 
dermis  (k,  phase  contrast  im- 
age of the  same field;  S,  sur- 
face; C, connective tissue; the 
bracket  demarcates  the  epi- 
dermis). Bars, 10 ~m. 
nized  by  both  mAb  Sym-TJ-E150  and  the  polyclonal 
guinea pig antibodies (Fig. 2 b, lane 5). 
With  a  randomly  primed  700-bp cDNA  probe,  synthe- 
sized  using  a  nested  deletion  fragment  representing  the 
most  5'  sequence  of  clone  2a-l-2B,  we  rescreened  the 
same  cDNA  library  and  cloned  three  positive  recombi- 
nants, one of which was a full-length cDNA clone of ~3.66 
kb (Fig.  3) ,~,hich overlapped  completely at the  3'-end of 
clone 2a-l-2B. This clone contained  a consensus initiation 
codon (Kozak, 1989) at position  111, a  3.32-kb open read- 
ing frame, followed  by a  135-bp non-coding  region and  a 
consensus  polyadenylation  signal.  This  cDNA  clone  en- 
coded  a  l142-aa  polypeptide,  i.e.,  symplekin,  with  a  pre- 
dicted mass of 126.5 kD and a pI of 6.25. We were able to 
identify  by  electrospray  mass  spectrometry  13  internal 
tryptic fragments  of symplekin, enriched  by cell fraction° 
ation,  detergent  extraction  and  ion  exchange  chromatog- 
raphy, that were identical  to segments of the aa sequence 
derived from the cDNA clone (Fig. 3). 
On sequence comparisons symplekin has not shown sig- 
nificant homology to any of the known proteins present in 
the data bases, including the tight junction-associated  pro- 
teins  cingulin,  ZO-1,  ZO-2,  and  other  MAGUK  proteins 
(Fig. 3). Symplekin also does not contain the extended se- 
quence  motif  which  the  tight  junction  "7H6  antigen" 
(Zhong et al.,  1993;  Mori  et al.,  1996)  shares with several 
The Journal of Cell Biology, Volume 134, 1996  1008 Figure 6.  Double-label immunostaining showing the location of symplekin (a and d) relative to 13-catenin  (b) or protein ZO-1 (d) in cryo- 
sections of human intestinal epithelia such as colon (a and b) or duodenum (c and d). Symplekin is restricted  precisely to the zonula oc- 
cludens (a and c), colocalizing with protein ZO-1 (d) whereas the adherens junction protein 13-catenin  shows a different subapical zonu- 
lar staining and also complex punctate arrays along the lateral cell--cell  contact borders. L, lumen. Bars, 10 Ixm. 
of the  "chromosomal segregation proteins"  of the  yeast 
Smclp family (Strunnikov et al., 1993). 
The aa sequence of symplekin displays several extended 
hydrophilic segments in the amino-terminal half whereas 
the carboxy-terminal half is  characterized by alternating 
short hydrophobic and hydrophilic aa stretches. A possible 
nuclear localization signal is located at aa positions 213- 
228, and several putative phosphorylation sites are spread 
throughout the sequence. 
Solubility and Stability Properties 
To determine the  solubility properties  of symplekin we 
performed cell fractionation  and  extraction experiments 
using  either PLC  (Fig.  4,  a-a")  or  Caco-2  (not  shown) 
cells. After low speed centrifugation of cells gently lysed in 
hypotonic buffer, the bulk of symplekin remained in the 
low  speed  pellet,  although  some  of the  protein was  re- 
leased from the pellet material upon resuspension in the 
same buffer. Symplekin could be partially extracted in al- 
kaline low salt (10 mM sodium bicarbonate, pH 9) or in 
high salt (0.5 M NaC1) buffers. However, complete extrac- 
tion of the protein into a soluble state was only obtained 
by further  non-ionic  detergent  solubilization  of the  ex- 
tracted pellets, Symplekin then remained soluble, after the 
removal of detergent by temperature-induced phase sepa- 
ration  and  subsequent  buffer exchange,  although in  the 
absence  of detergent and/or  divalent  cation  chelators it 
displayed its susceptibility to proteolytic degradation (Fig. 4). 
Keon et al. Symplekin, a Tight Junction Plaque Protein  1009 Figure 7.  Double-label immunofluorescence microscopy, show- 
ing the maintenance of symplekin's apical assembly at the zonula 
occludens  in  a  cryosection through  a  human  colon carcinoma 
comparing symplekin (a, mAb Sym-TJ-E150) and E-cadherin (b, 
rabbit antibodies). Note that also in the carcinoma symplekin is 
restricted to a polar zonule (a) whereas E-cadherin shows the dis- 
play of the zonular as well as punctate adherens junctions along 
the lateral walls. L, lumen. Bar, 10 Ixm. 
lmmunofluorescence  Localization of Symplekin at 
Tight Junctions in Tissues 
To  define  the  localization  of  symplekin  in  diverse  cell 
types we performed immunostaining experiments on cryo- 
sections  of  normal  human  tissues,  including  stomach, 
duodenum, pancreas, liver, testis, epidermis, lymph nodes, 
and fetal brain, as well as carcinomas (e.g., Figs. 5 and 6). 
In polarized epithelia, mAb Sym-TJ-E150 reacted specifi- 
cally with the tight junction-containing peripheral  ring at 
the immediate  sub-apical level (Fig. 5, a-c, f,  and g), and 
such a reaction was also seen in alveolar as well as ductal 
(Fig.  5, d  and e) cells of various glands, in adenocarcino- 
mas (e.g., Fig. 5 c), and in the "junctional specializations" 
of Sertoli cells of testis (Fig. 5 i). No reaction was detected 
in endothelia of vessels of various types and calibers (e.g., 
Fig. 5, g and h), including brain capillaries, in stratified ep- 
ithelia as in epidermis  (Fig. 5, j  and k), in the intercalated 
disks and the Purkinje fiber cells of the heart and in lymph 
nodes (not shown). 
We  further  determined  symplekin's  location  with  re- 
spect to other plaque proteins  specific for tight junctions, 
Figure 8.  Confocal laser-scanning micrographs of double-label 
immunostaining of symplekin (red fluorescence) in human colon 
tissue  relative to (in green fluorescence) either desmoplakin (a), 
tx-catenin  (b), or protein ZO-1 (c and d), showing the composi- 
tional  and  positional  distinction  of the  zonula  occludens  from 
both  desmosomes  and  adherens junctions.  Symplekin  staining 
could be resolved from both desmoplakin (a) and tx-catenin  (b) 
staining patterns  where in both cases  symplekin was  located at 
the apical-most position of the tripartite junctional zone. In con- 
trast, symplekin staining could not be resolved from that of pro- 
tein ZO-1  (c and d),  reflecting their colocalization in the tight 
junction-containing zone (yellow-orange). In e and f, a computer- 
assisted  frame off-set (20 pixels)  of the images shown in c and d 
along the abscissa  was produced to artificially  separate the indi- 
vidual fluorochrome emissions  to demonstrate the similar  rela- 
tive intensities  of the respective antibody reactions and to under- 
score their colocalization. L, lumen. Bar, 10 ~m. 
adherens  junctions,  or  desmosomes.  Symplekin  clearly 
colocalized  with  protein  ZO-1  in  all  epithelia  examined 
(Fig. 5, g and h, and Fig. 6, c and d), but not in endothelia 
(Fig.  5,  g  and  h).  The  larger  subapical  region  displayed 
similar  immunostaining  for  symplekin  and  the  adherens 
The Journal of  Cell Biology,  Volume 134, 1996  1010 Figure 9.  Electron microscopy localization of symplekin to the tight junction-associated plaque, using mAb Sym-TJ-E150 on cryosec- 
tions from human colon (a-c) or detergent-permeabilized cultured PLC cells (d), incubated with primary and secondary 5-nm gold-cou- 
pled antibodies before fixation and embedding, shown with (a, b, and d) or without (c) the immunogold silver enhancement technique. 
The gold particles specifically  decorated the apical tight junction (TJ)-associated cytoplasmic plaque of the zonula occludens (a and b), 
and this was also seen after retraction of the plaque from the membrane under slightly hypotonic conditions (c, bracket). Note that sym- 
plekin immunogold is practically absent from the plaque structures of the zonula adhaerens (ZA; a-c, brackets) and of desmosomes (D). 
The orientation of the gold particles to one side of the plaque structure in longitudinal sections (c, inset in lower right presents a magni- 
fication) suggests that symplekin, or at least this epitope, is located between the membrane and the plaque. (d) In PLC cell monolayers, 
gold particles densely decorated one plaque zone, the tight junction-containing zone (TJZ) along cell-cell contact borders, but were es- 
sentially absent from a similarly  dense adjacent plaque zone representing the adherens junction zone (AJZ). MV, microvilli; AS, apical 
surface. Bars: (a-d) 0.2 ~m; (inset) 0.1 Izm. 
junction marker proteins et-catenin, 13-catenin, and E-cad- 
herin.  However,  the  symplekin  staining  was  always  re- 
stricted to a  narrow near-apical belt whereas  the catenins 
and E-cadherin were found in addition  in numerous sites 
along the lateral cell walls (Fig. 6, a and b, and Fig. 7, a and b). 
The  zonular  apical  reaction  of symplekin  was  strikingly 
different  from  the  punctate  immunostaining  pattern  of 
desmoplakin along the lateral cell walls (Fig. 8 a). Observ- 
ing double-label immunofluorescence stainings with laser 
scanning confocal microscopy it was clear that symplekin 
did not co-localize with the plaque proteins of both the ad- 
herens  junctions  and  the  desmosomes,  but  was  located 
more apically (Fig. 8, a and b), together with the tight junc- 
tion plaque protein ZO-1 (Fig. 8, c-y). 
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and  double-(c  and  d)  label 
immunofluorescence micros- 
copy of symplekin (a-c) and 
protein  ZO-1  (d)  in  mono- 
layer cultures of human epi- 
thelial  cells,  showing  the 
dual  location  of symplekin. 
(a)  Caco-2  cell  monolayers 
treated in the absence of de- 
tergent according to protocol 
1  (see  Materials  and  Meth- 
ods). Under these conditions, 
optimized  for  minimal  pro- 
tein  loss  and  redistribution, 
intense  fluorescence  is  seen 
at  cell-cell junctions  and  in 
the  nucleoplasm  (nucleoli 
are  negative)  whereas  free 
cell  edges are  negative.  Not 
also,  in the  center,  a  cell  in 
mitosis (late anaphase), with 
transient  dispersion  of sym- 
plekin  over  the  cytoplasm. 
(b)  Caco-2  cell  monolayers 
treated in the presence of de- 
tergent (5 min) according to 
protocol  2,  showing  intense 
junctional staining but greatly 
reduced  nuclear  staining.  (c 
and d) Double-label immun- 
ostaining  of  symplekin  (c) 
and protein ZO-1 (d) in PLC 
cell monolayers treated briefly 
with  detergent  (2  min)  ac- 
cording to protocol 2.  Note 
the identical staining pattern 
of the two proteins at the in- 
tercellular borders. With the 
shorter duration of exposure 
to  detergent,  symplekin  is 
still  detected  in  the  nucleus 
(c) whereas  protein ZO-1 re- 
action is very weak. Bars, 5 txm. 
lmmunogold Electron Microscopic Localization 
Using  different  immunogold  labeling  protocols,  with  or 
without the "silver enhancement" technique, we were able 
to localize symplekin specifically to the electron-dense cy- 
toplasmic undercoat of the zonula occludens  (Fig. 9), thus 
directly demonstrating symplekin as a tight junction plaque 
protein.  In cryosections of human colon tissue, for exam- 
ple, immunogold particles decorated exclusively the plaques 
at either side of the tight junction, but were practically ab- 
sent from the plaque structures of both the zonula adhaer- 
ens and the desmosomes (Fig. 9, a-c). Furthermore, the as- 
sociation  of symplekin with  the  plaque  was underscored 
by its  maintenance  during  retraction  of the  plaque  from 
the membrane under slightly hypotonic conditions (Fig. 9 
c). From the immunogold distribution pattern displayed in 
longitudinal sections (Fig. 9, insert) symplekin appeared to 
be situated in a juxtmembranous position at the interface 
between the plaque structure and the membrane proper. 
Similar  results  were obtained in cultured  cells.  In elec- 
tron micrographs of silver-enhanced immunogold localiza- 
tion  of symplekin  in  PLC  hepatocellular  carcinoma  cell 
monolayers, the concentration of gold particles in the tight 
The Journal of Cell Biology.  Volume 134. 1996  1012 Figure 11.  Double-label immunofluorescence localization of sym- 
plekin (a) and desmoplakin  (b) in monolayers of MCF-7 breast 
carcinoma  cells, treated according to protocol 2 (see Materials 
and Methods; C, phase contrast image of the same field). Symple- 
kin staining is zonular, reflecting the organization  of tight junc- 
tion structures in this culture, in contrast to the distinct, desmo- 
some-typical punctate staining pattern of desmoplakin. Note still 
detection of some symplekin in the nucleus, in contrast  to the 
lack of nuclear  staining of the plaque  protein desmoplakin  (b). 
Bar, 5 I~m. 
junction plaque compositionally distinguished  this struc- 
ture from the otherwise morphologically indistinguishable 
subjacent plaque of the zonula adhaerens (Fig. 9 d). 
Immunofluorescence Microscopy of Cultured 
Epithelial Cells 
In colonies of cultured cells derived from polarized epithe- 
lia or adenocarcinomas, symplekin could be localized to a 
zonular region of ceU-ceU contact but was absent from the 
"free" cell surfaces not bordering on another cell (Figs. 10 
and 11). Again, coimmunostaining of symplekin with ZO-1 
was obvious (Fig, 10, c and d), whereas desmoplakin (Fig. 
11) and the adherens junction markers (Fig. 12) displayed 
distinctly different staining patterns  and positions. Laser 
scanning confocal microscopy (Fig.  12) allowed us to re- 
solve directly the zonula adhaerens, seen by its E-cadherin 
reaction, from the more apically placed zonula occludens, 
also demonstrating that in monola,yers of cultured cells the 
adherens junctions and the tight junction domains are spa- 
tially and compositionally distinct. 
Surprisingly, we  noticed, with  mAb  Symp-TJ-E150 as 
well as the guinea pig antibodies, an intense immunoreac- 
tion in the nucleoplasm, excluding the nucleoli, which var- 
ied according to the specific preparative conditions: while 
with extremely rapid fixation in methanol and after short 
wash and incubation times strong staining was only seen in 
the nucleoplasm (not shown), more extended incubations 
showed the simultaneous appearance of the nuclear and 
the junctional immunoreaction (Figs. 10, a and c, 11 a and 
12), and the latter was usually enhanced when a detergent 
step was included. Increasing times of detergent treatment 
and washes resulted in a  reduction of nucleoplasmic and 
thus  a  more  prominent  junctional  immunofluorescence 
(Fig. 10 b). The significance of this selective nucleoplasmic 
reaction of symplekin was also evident from the redistri- 
bution of this protein during mitosis when it transiently 
spreads over the cytoplasm (an anaphase cell is shown in 
Fig.  10 a)  but is effectively reaccumulated into the telo- 
phase  daughter nuclei.  The specificity of the  strong  nu- 
clear  immunostaining  of symplekin was  further  demon- 
strated  in  double-labeling  experiments,  in  comparison 
with, for example, protein ZO-1 (Fig. 10, c and d) and des- 
moplakin (Fig. 11, a-c). 
In culture cell lines derived from non-polarized epithelia 
such as in human HaCaT keratinocytes and A-431 squa- 
mous carcinoma cells we noted a  heterogeneous immu- 
nostaining reaction in that only some cells showed short 
regions of symplekin positivity at cell-cell borders, often 
in whiskers or punctate arrays (not shown). In these cells 
as well as in non-epithelial cells devoid of tight junctions 
but forming extensive adherens junctions, such as human 
endothelial HuVEC cells, calf lens-, rat RVF- and murine 
3T3-cells or in cells that form no stable junctions at  all, 
such as lymphoma and erythroleukemia cells, we only and 
consistently observed the nuclear reaction. 
Immunofluorescence Microscopy of Nuclear Symplekin 
The detection of symplekin in the nucleus of a broad range 
of cultured cell types prompted us to  examine whether 
symplekin could also be detected in the nuclei of solid tis- 
sues. As we had originally noted the high extractability of 
Keon et al. Symplekin, a Tight Junction Plaque Protein  1013 Figure 12.  Double-label  immunofluorescence comparison of symplekin (red) with E-cadherin (green) in a monolayer culture  of MCF-7 
cells, treated according to protocol 1, as viewed by laser-scanning confocal microscopy. Symplekin and E-cadherin do not colocalize, but 
shadow one another, resulting in the distinction of the zonula occludens (red contour line) from the zonula adhaerens (green line), which 
is clearly subjacent to the zonula occludens. Again, using a protocol designed to minimize losses of soluble proteins and redistributions, 
an intense and specific nuclear reaction of symplekin is observed. Bar, I0 txm. 
soluble  nuclear  proteins  to  be  a  specific  problem  with 
thawed sections of frozen tissue, we used several alterna- 
tive  fixation  protocols  for  immunofluorescence  localiza- 
tion (for details see Materials and Methods; a more com- 
prehensive report of these  results  is  in  preparation):  (a) 
Fixation  in  acetone for 10 min at  -20°C;  (b)  fixation in 
Carnoy solution  (methanol/chloroform/acetic acid) for 20 
min followed by an ethanol wash for 10 min; and (c) form- 
aldehyde  fixation  for  15  min.  Furthermore,  for  each  of 
these  fixation protocols other  variables were  also  tested 
such as treatments with detergent, Triton TX-100, and var- 
ious  antibody incubation  times. By using several marker 
antibodies as controls it became clear that different anti- 
gens require different procedures for optimal nuclear re- 
tention and accurate detection in situ. 
Figs. 13 and 14 present some results obtained with near- 
optimal protocols, showing  intense  nuclear  immunofluo- 
rescence  of  epithelial  and  non-epithelial  (submucosal) 
cells in sections through human colon carcinoma (Fig.  13, 
a-b') and esophagus (Fig. 14, a-b') after Carnoy fixation. 
In  contrast  to  nuclear  localization  this  protocol  yielded 
only poor reactions at the tight junctions of the zonula oc- 
cludens (arrows in Fig. 13 a). It is also notable that in strat- 
ified epithelia such as esophagus (Fig. 14), tongue mucosa, 
and epidermis (not shown), which lack a zonula occludens, 
the nuclei are the only site of symplekin immunoreaction, 
and that this nuclear  reaction is seen in the  proliferative 
compartment of the basal cell layer as well as in the non- 
proliferative compartment of the upper strata. Other pro- 
tocols, including those using formaldehyde or involving a 
short treatment with Triton X-100, revealed a relatively in- 
tense tight junction reaction but a weaker nuclear staining. 
The  non-epithelial  cells  showing  strong  nuclear  immu- 
nostaining in tissue sections included fibroblasts, endothe- 
lial cells, and lymphocytes, and the latter reaction was par- 
ticularly impressive in lymph node sections (not shown). 
Discussion 
In this study we have identified and characterized symple- 
kin, a novel and unique human protein with a polypeptide 
molecular mass of 126.5 kD, which is a specific component 
of the  zonula  occludens plaque  associated with the  tight 
junctions  of polar epithelia and  Sertoli cells of testis but 
not of vascular endothelia. Both by its aa sequence and by 
its intracellular distribution, symplekin is notably different 
from other  tight junction-associated  proteins  as its junc- 
tional  localization  is  clearly more specific for tight junc- 
tions than protein ZO-1, so far the most widely used "tight 
junction  marker," as  it does not  occur at other  kinds  of 
junctions such as between vascular endothelial cells in vivo 
and in vitro, between the foot processes of kidney podocytes, 
between fibroblasts or muscle cells, or in the intercalated 
disks of myocardium (for protein ZO-1  see Stevenson et 
al., 1986; Schnabel et al., 1990; Howarth et al., 1992,  1994; 
Itoh  et  al.,  1993;  Miragall  eta|.,  1994).  Similarly,  it  has 
been reported that in uncoupled canine kidney epithelial 
cells of line  MDCK protein ZO-1  localizes in aggregates 
deep in the cytoplasm where it can be associated with the 
E-cadherin/u-  and  13-catenin/plakoglobin  complex,  and 
that it is dispersed over the cytoplasm in Moloney sarcoma 
virus-transfected MDCK cells (Rajasekaran et al.,  1996). 
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chemistry  showing  nuclear 
immunofluorescence  staining 
with  mAb  Sym-TJ-E150  (a; 
a',  phase  contrast  optics  of 
the  same  field)  and  poly- 
clonal  guinea pig  antibodies 
(b; b', phase contrast) on cry- 
ostat sections through frozen 
human  colon  carcinoma  re- 
acted  according  to  protocol 
B of Materials  and Methods, 
including  Carnoy  fixation 
and  30-min  incubation  with 
primary antibodies.  Note in- 
tense nuclear immunostaining 
in the epithelium-derived cells 
as  well  as  in  non-epithelial 
(stromal) cells (stroma marked 
by brackets). Arrows point to 
the cell apex regions showing 
only  weak  residual  zonula 
occludens immunostaining un- 
der these conditions (compare 
with Fig. 7). Bars, 5 p~m. 
We are currently studying the mode of association of sym- 
plekin with the forming zonula occludens to test the possi- 
bility  of  transient  complexes  with  components  of  the 
zonula adhaerens ensemble, as recently reported by Raja- 
sekaran et al. (1996). 
Our  immunohistochemical  results  with  actual  carcino- 
mas also show that in differentiated colon carcinomas and 
adenocarcinomas symplekin is assembled in  a  tight junc- 
tion-associated plaque structure in a near-apical position, 
similar to  its  location  in  normal polarized  epithelia.  We 
therefore  propose  to  use  symplekin  as  a  differentiation 
marker in the differential diagnosis of tumors, notably for 
different types of carcinomas and certain "epithelioid" tu- 
mors. 
Remarkably,  we  detected  symplekin  and  its  encoding 
mRNA not only in cells that are connected by tight junc- 
tions  or  have  the  developmental  potential  to  form  a 
zonula  occludens  but  also in  a  wide range  of other  cells 
and tissues devoid of tight junctions or even of stable cell- 
cell junctions in general. Such symplekin-producing, non- 
tight junction-forming cells do not  only include  cultured 
cells derived from stratified squamous epithelia or squa- 
mous cell carcinomas (e.g., lines HaCaT and A-431) but also 
non-epithelial  cells  such  as  various  endothelial  cultures, 
lens-forming cells  and  fibroblasts,  and  totally uncoupled 
cells such as lymphocytes, lymphoma cells and erythroleu- 
kemia cells. While in some of these cells, immunolocaliza- 
tion revealed symplekin in occasional small dot-, whisker- 
or ring-like structures at the cell surface or in the cytoplasm 
(immunoelectron microscopic identification of these sparse 
structures is underway), all of the cultured cells and tissues 
examined have shown intense symplekin immunoreaction 
in the nuclear interior. In fact, under the specific appropri- 
ate immunolocalization conditions, i.e., preventing extrac- 
tion of diffusible proteins, very strong symplekin labeling 
has consistently been seen throughout the entire nucleo- 
plasm, and this is also the case in the tight junction-cou- 
pled polar epithelial cells. Consequently, in cells devoid of 
tight junctions, the nucleus is the only demonstrable loca- 
tion of accumulated symplekin. 
The finding of a junctional plaque protein in the cell nu- 
cleus, while surprising at first sight, is not without prece- 
dence. For example, the occurrence of protein ZO-1 in the 
nuclei of certain cells has recently been demonstrated by 
immunolocalization  and  fractionation  experiments (Got- 
tardi et at., 1995) although, as shown in the present study, 
nuclear protein ZO-1 is much less apparent and less stably 
bound  in  the  nucleus.  When  exogenous plakoglobin, the 
Keon et al. Symplekin, a Tight Junction Plaque Protein  1015 Figure  14.  Nuclear  symplekin  immunostaining on cryostat  sec- 
tions through frozen human esophageal tissue, using mAb Sym- 
TJ-E150 after Carnoy fixation (protocol B) and detergent wash 
(0.2% Triton X-100, protocol 2 of Materials and Methods). Note 
exclusively nuclear localization in ceils of the basal as well as su- 
prabasal strata (a, survey picture; b, higher magnification). The 
dashed line denotes the level of the basal lamina, the arrows in b 
point to the finely granular-appearing reaction in the nuclei of 
the upper cell layers. Bars, 5 ixm. 
plaque protein common to adhering junctions of both the 
desmosomal  and  the  zonula adhaerens type,  was  intro- 
duced into Xenopus laevis embryos it was found in both 
junctions and nuclei, and the same was noted for the adhe- 
rens junction plaque  protein,  [3-catenin (Karnovsky and 
Klymkowsky, 1995; Funayama et al., 1994). Moreover, the 
desmosomal plaque proteins, plakophilin 1 and plakophi- 
lin 2, have been shown to be proteins of a dual location, as 
they occur in the nucleoplasm of a large diversity of cells 
and tissues as well as in desmosomal plaques of various ep- 
ithelial and non-epithelial cells and tissues (Schmidt et al., 
1994; Heid et al., 1994; Mertens et al., 1996).  Plakophilin 
has even been identified in the manually isolated nuclei 
(germinal vesicles) of amphibian oocytes (Franke, H.W.W., 
unpublished  results).  Although  possible  interactive  nu- 
clear partners of any of these plaque proteins have not yet 
been identified, their dual residence at cell junctions and 
in the nucleus has been taken, together with similar obser- 
vations for the  13-catenin-related Drosophila protein en- 
coded by the Armadillo gene, as an indication for a  role 
not only in junction structure formation and cell-cell cou- 
pling but also as nuclear signaling molecules in complex 
signal transduction pathways (for reviews see, e.g., Peifer, 
1995; Takeichi, 1995). 
The perplexing finding that the tight junction-associated 
plaque protein symplekin, and also other junctional plaque 
proteins, also occur as "housekeeping" proteins in the nu- 
cleus of a very wide range of different cell types forces one 
to reconsider the views of the topogenesis, evolution and 
the functions of these proteins. Apparently, they are not 
synthesized in relation to the appearance of certain types 
of cell--cell junctions in the course of specific pathways of 
cell differentiation. They rather seem to represent gener- 
ally and genuinely nuclear proteins which in certain cell 
differentiations can be recruited to contribute to the as- 
sembly of specific kinds of junctional plaques: plakophilins 
1  and  2  to  desmosomal  plaques,  13-catenin  to  adherens 
junction plaques, plakoglobin to both, and symplekin to the 
plaque of tight junctions. Clearly, our observations of nu- 
clear  immunostaining  of symplekin  in  non-proliferative 
states such as in densely grown cell cultures or in upper 
strata of squamous epithelia indicate that, in contrast to 
what has been reported for protein ZO-1 (Gottardi et al., 
1995), symplekin does not appear in the nucleus only in re- 
sponse to replication and cell proliferation. Obviously, it 
will be important to determine the possible modifications 
and/or complex of partners that are involved in the regula- 
tion of the specific topogenic assembly of symplekin. 
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